Potential mechanism of resistance to anti-BCMA immunotherapies. Three mechanisms are target dependent, including antigen loss, BCMA shedding by sBCMA, and the secretion of anti-drug antibodies. Two mechanisms of resistance are T-cell dependent, including T-cell exhaustion and the emergence of a nonpermissive microenvironment.